Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | KMO | O15229 | 1/20 | 0.35 |
| ▸ | ACMSD | Q8TDX5 | 2/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.34 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.34 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.34 |
| ▸ | JAK2 | O60674 | 2/20 | 0.34 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | HTR7 | P34969 | 1/20 | 0.34 |
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
| ▸ | HNF4A | P41235 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
| ▸ | AGXT | P21549 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9971871 | 0.98 | MGLL (0.39) | MGLLMAOAHDAC4HDAC2HDAC8 | |
| SCHEMBL9971939 | 0.98 | MGLL (0.39) | MGLLMAOAHDAC4HDAC2HDAC8 | |
| SCHEMBL14446783 | 0.94 | MGLL (0.37) | MGLLMAOAHDAC4HDAC2HDAC8 | |
| SCHEMBL19817603 | 0.91 | ALDH1A1 (0.38) | MGLLMAOAHDAC4HDAC2HDAC8 | |
| SCHEMBL14867176 | 0.90 | JAK2 (0.39) | MGLLMAOAHDAC4HDAC2HDAC8 | |
| SCHEMBL20403905 | 0.89 | MGLL (0.34) | MGLLMAOAHDAC4HDAC2HDAC8 | |
| SCHEMBL16305280 | 0.88 | CETP (0.37) | MGLLHTR1AHTR7AGXT | |
| SCHEMBL14867168 | 0.88 | HSD17B1 (0.39) | MGLLHDAC4HDAC2HDAC8ACMSD | |
| SCHEMBL13511249 | 0.88 | CYP2C19 (0.35) | MGLLALDH1A1MCL1 | |
| SCHEMBL22669636 | 0.87 | MGLL (0.35) | MGLLMAOAHDAC4HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9136478-B2 | Organic light emitting device and display panel using the same method, terminal, and server for implementing fast playout | LG DISPLAY CO., LTD. (KR) | 2015-09-15 | — | — | US | disclosed |
| US-9136478-B2 | Organic light emitting device and display panel using the same method, terminal, and server for implementing fast playout | LG DISPLAY CO., LTD. (KR) | 2015-09-15 | — | — | US | disclosed |
| US-20130092910-A1 | ORGANIC LIGHT EMITTING DEVICE AND DISPLAY PANEL USING THE SAME | LG DISPLAY CO., LTD. (KR) | 2013-04-18 | — | — | US | disclosed |
| US-20130092910-A1 | ORGANIC LIGHT EMITTING DEVICE AND DISPLAY PANEL USING THE SAME | LG DISPLAY CO., LTD. (KR) | 2013-04-18 | — | — | US | disclosed |
| US-20120153815-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
| US-20120153815-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
| US-20110175521-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2011-07-21 | — | — | US | disclosed |
| US-20110175521-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2011-07-21 | — | — | US | disclosed |
| US-20100160687-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20100160687-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20070142671-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD (JP) | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110175521-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | SCO2, CHRM1, CHRM4 | MGLL 3499/4885MAOA 1500/4885HDAC4 1409/4885 |
| US-20100160687-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | SCO2, CHRM1, CHRM4 | MGLL 3499/4885MAOA 1500/4885HDAC4 1409/4885 |
| US-20120153815-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | ARL1, RIF1, EML4 | MGLL 3707/4885MAOA 1025/4885HDAC4 2414/4885 |
| US-20070142671-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | SCO2, CHRM1, CHRM4 | MGLL 3499/4885MAOA 1500/4885HDAC4 1409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.